These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21617854)

  • 41. Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules.
    Luo Q; Zhang Y; Wang N; Jin G; Jin H; Gu D; Tao X; Huo X; Ge T; Cong W; Wang C; Qin W
    Oncotarget; 2015 Mar; 6(9):6989-99. PubMed ID: 25749520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients.
    Shalaby SM; El-Shal AS; Abdelaziz LA; Abd-Elbary E; Khairy MM
    Gene; 2018 Feb; 644():66-73. PubMed ID: 29080834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.
    Kim MS; Chang X; Yamashita K; Nagpal JK; Baek JH; Wu G; Trink B; Ratovitski EA; Mori M; Sidransky D
    Oncogene; 2008 Jun; 27(25):3624-34. PubMed ID: 18223688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
    Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
    Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
    Dhingra K; Sahin A; Emami K; Hortobagyi GN; Estrov Z
    Breast Cancer Res Treat; 1998 Mar; 48(2):165-74. PubMed ID: 9596488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
    Metz S; Naeth G; Heinrich PC; Müller-Newen G
    J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progesterone and interferon tau regulate leukemia inhibitory factor receptor and IL6ST in the ovine uterus during early pregnancy.
    Song G; Satterfield MC; Kim J; Bazer FW; Spencer TE
    Reproduction; 2009 Mar; 137(3):553-65. PubMed ID: 19060097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.
    Lind GE; Kleivi K; Meling GI; Teixeira MR; Thiis-Evensen E; Rognum TO; Lothe RA
    Cell Oncol; 2006; 28(5-6):259-72. PubMed ID: 17167179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumor.
    Qi J; Zhu YQ; Huang MF; Yang D
    World J Gastroenterol; 2005 Apr; 11(13):2022-5. PubMed ID: 15800999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
    Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
    Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
    Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
    J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
    Brait M; Ling S; Nagpal JK; Chang X; Park HL; Lee J; Okamura J; Yamashita K; Sidransky D; Kim MS
    PLoS One; 2012; 7(9):e44951. PubMed ID: 23028699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
    Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased expression of repulsive guidance molecule member A by DNA methylation in colorectal cancer is related to tumor progression.
    Zhao ZW; Lian WJ; Chen GQ; Zhou HY; Wang GM; Cao X; Yang HJ; Hou YP
    Oncol Rep; 2012 May; 27(5):1653-9. PubMed ID: 22367090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.